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Anti-inflammatory activity of 
immunoglobulin G results from Fc 
sialylation
Immunoglobulin G (IgG) is the major serum immunoglobulin 
and is principally responsible for the recognition, neutralization, 
and elimination of pathogens and toxic antigens. It mediates 
pro- and anti-infl ammatory activities through the engagement 
of its Fc fragment (Fc) with distinct Fcγ receptors (FcγRs). One 
class of Fc–FcγR interactions generates proinfl ammatory eff ects 
of immune complexes and cytotoxic antibodies. In contrast, 
therapeutic intravenous γ-globulin and its Fc fragments are anti-
infl ammatory. To determine whether specifi c glycoforms of IgG 
are involved in modulating the eff ector functions of antibodies, 
Kaneko et al. explored the role of specifi c Asn297-linked 
carbohydrates in mediating the cytotoxicity of IgG monoclonal 
antibodies of defi ned specifi city. Next, the investigators 
examined the role of N-linked glycans in the anti-infl ammatory 
activity of immunoglobulins with established anti-infl ammatory 
activity. Th ese distinct properties of the IgG Fc resulted from 
diff erential sialylation of the Fc core polysaccharide. IgG 
acquired anti-infl ammatory properties upon Fc sialylation, 
which was reduced upon the induction of an antigen-specifi c 
immune response. Upon antigenic challenge by a potential 
pathogen, the antigen-specifi c IgG antibodies can switch to 
a population with reduced sialic acid that is thus capable of 
mediating antigen clearance and a protective infl ammatory 
response through the engagement of subclass-specifi c FcγRs on 
eff ector cells. (Science 2006; 313: 670–673)
Detlef Schlöndorﬀ 
Loss of the tumor suppressor 
Vhlh leads to upregulation of 
Cxcr4 and rapidly progressive 
glomerulonephritis
Rapidly progressive glomerulonephritis (RPGN) is a clinical 
syndrome characterized by loss of renal function within days to 
weeks and by glomerular crescents on biopsy. Th e pathogenesis 
of this disease is unclear, but circulating factors are believed 
to have a major role. In a recent study, Ding et al. showed that 
deletion of the Von Hippel–Lindau gene (Vhlh) from intrinsic 
glomerular cells of mice is suffi  cient to initiate a necrotizing 
crescentic glomerulonephritis and the clinical features that 
accompany RPGN. Loss of Vhlh leads to stabilization of 
hypoxia-inducible factor α subunits (HIFs). Using gene 
expression profi ling, we identifi ed de novo expression of 
the HIF target gene Cxcr4 in glomeruli from both mice 
and humans with RPGN. Th e course of RPGN is markedly 
improved in mice treated with a blocking antibody against 
Cxcr4, whereas overexpression of Cxcr4 alone in podocytes 
of transgenic mice is suffi  cient to cause glomerular disease. 
Collectively, these results indicate an alternative mechanism for 
the pathogenesis of RPGN and glomerular disease in an animal 
model and suggest novel molecular pathways for intervention 
in this disease. (Nat Med 2006; 12: 1081–1087)
Jai Radhakrishnan
Mechanisms by which increased 
osmolality causes hypertension
Increasing evidence supports a role for body fl uid osmolality in 
the regulation of blood pressure. For example, acute increases in 
osmolality rapidly elevate blood pressure as well as sympathetic 
nerve activity to several vascular beds. Studies with a model of 
salt-sensitive hypertension, the deoxycorticosterone-treated 
rat consuming excess salt (the DOCA-salt rat), have shown 
that normalization of osmolality results in profound decreases 
in blood pressure. Osmoreceptors are present in numerous 
organs, including the liver, kidney, and brain, but it is likely that 
the osmoreceptors in the brain are involved in blood pressure 
regulation. Osmoreceptors in the forebrain circumventricular 
organs are exquisitely sensitive to minute changes in osmolality 
and are known to mediate the sympathoexcitatory eff ects of 
hyperosmolality during water deprivation. Hence, O’Donaughy 
et al. postulated that during DOCA-salt hypertension, increased 
osmolality acts in the brain to perhaps increase sympathetic 
nerve activity and thereby induce hypertension. To test this, 
they examined the eff ect of acute reduction of the osmolality of 
 At 3 weeks of age, glomeruli from Vhlh Pod-Cre–/– mice have dilated 
capillary loops (arrows). 
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the blood perfusing the brain (by infusion of hypotonic fl uid via 
the carotid artery) in rats with DOCA-salt hypertension.
Rats were uninephrectomized and received subcutaneous 
implants with or without DOCA and given 1% NaCl to 
drink. DOCA-salt rats developed hypertension, with blood 
pressure of about 160 mm Hg, as compared with Sham-salt 
animals (~107 mm Hg). Bilateral intracarotid infusion of 
hypotonic fl uid (osmolality: ~40 mOsm per liter), which 
lowers osmolality of blood to the brain by about 2%, rapidly 
decreased blood pressure in DOCA-salt rats (by 22 mm Hg) 
but not Sham-salt rats. Hypotonic fl uid infused intravenously 
did not lower blood pressure in DOCA-salt rats. Interestingly, 
in DOCA-salt rats pretreated with a V1 vasopressin receptor 
antagonist, intracarotid hypotonic infusion still decreased 
blood pressure, but to a much smaller extent (by 10 mm Hg). 
Finally, in DOCA-salt rats pretreated with the V1 antagonist 
and the ganglionic blocker hexamethonium, decreasing 
osmolality of blood to the brain did not reduce blood 
pressure. Th ese results indicate that in DOCA-salt rats, 
hypertonicity acts in the brain to cause hypertension, in part 
by stimulating vasopressin secretion and probably in part by 
stimulating the sympathetic nervous system. Th is and other 
recent studies highlight the potential role of osmolality in 
human hypertension. (Hypertension 2006; 48: 658–663)
Juan Oliver
A new player in epithelial–
mesenchymal transition
Epithelial–mesenchymal transition (EMT) is regulated by 
cell-to-cell interactions, cell interaction with the extracellular 
matrix, and multiple secreted proteins acting in an autocrine 
or paracrine fashion (for example, chemokines, cytokines, 
tyrosine/serine kinase ligands, and developmental regulators). 
EMT has emerged as a central process during embryonic 
development, cancer progression, metastasis, and chronic 
infl ammation/fi brosis; the latter is critically involved in 
many renal diseases. In cancer progression, complete EMT is 
defi ned by a metastable, fi broblastoid phenotype plus loss of 
E-cadherin and gain of vimentin.
To molecularly characterize the ‘complete EMT’ phenotype, 
Waerner et al. screened mouse mammary epithelial cells 
showing simple scattering or complete EMT for molecules 
involved in EMT and cancer metastasis. Th ey used an 
expression-profi ling assay that employs polysome-bound 
mRNAs and that, unlike other expression-profi ling methods, 
allows the identifi cation of RNAs whose translation, rather 
than their transcriptional profi le, is correlated with the 
relevant process. Th ey found a cluster of more than 30 genes 
specifi c for complete EMT, and the EMT/metastasis-specifi c 
expression of a protein that belongs to a recently discovered 
gene family (FAM3A–D) with no sequence homology to 
known genes. Th e FAM3C protein, which they referred to as 
interleukin-like EMT inducer (ILEI), was shown to be both 
necessary and suffi  cient to cause EMT (recombinant ILEI 
added to cells in collagen gels induced complete EMT), slow 
tumor growth, and late steps in metastasis. Abnormal ILEI 
expression was also associated with EMT in human colon 
cancer and predictive of metastasis formation and poor 
prognosis in human breast cancer. Discovery of ILEI thus 
adds a key player to the growing list of mechanisms governing 
EMT, cancer progression, and tumor metastasis and is a 
promising target for therapeutic intervention. Th e potential 
role of ILEI in renal EMT and renal fi brosis needs to be 
explored. (Cancer Cell 2006; 10: 227–239)
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EpC40-GFP control tumors and EpC40-ILEI induced tumors. 
Reprinted from Cancer Cell, vol. 10, Waerner et al., ILEI: A cytokine essential 
for EMT, tumor formation, and late events in metastasis in epithelial cells, 
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